¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1 : 2023-07-06

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1 : 2023-07-06
±³À°ÀÏÀÚ : 2023-07-06
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D

±³À°ÁÖÁ¦ : APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1

ÁÖÃÖ±â°ü : ´ëÇÑ°£¾ÏÇÐȸ
´ã´çÀÚ : Ȳ¼öÁ¤
¿¬¶ôó : 02-373-1005  

À̸ÞÀÏ : apple2023@hbni.co.kr

±³À°Á¾·ù : ³»°ú, ¿Ü°ú, ¿µ»óÀÇÇаú, ¹æ»ç¼±Á¾¾çÇаú, º´¸®°ú

Âü¼®¿¹»óÀÎ : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 6 ½Ã°£ 5ºÐ

¼¼ºÎ¼ö°­·á : 300,000¿ø

ºñ°í [Regular Registration-Non-Member Rate]Doctor, Healthcare Professionals: KRW 300,000 / USD 300Fellow, Resident, Researcher, Others: KRW 250,000 / USD 250Poster Presenter: KRW 100,000 / USD 100[Regular Registration-Member Rate]Doctor, Healthcare Professionals: KRW 250,000 / USD 250Fellow, Resident, Researcher, Others: KRW 200,000 / USD 200Poster Presenter: KRW 100,000 / USD 100


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 09:00~09:20 Changing Etiology and Epidemiology of HCC: Asia and Worldwide Do Young Kim(Yonsei Univ.)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 09:20~09:40 New Concepts in the Imaging Diagnosis of HCC: Can Artificial Intelligence Help? Chih-Hung Hsu(National Taiwan Univ., Taipei)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 09:40~10:00 Molecular Heterogeneity in HCC and the Challenge of Identifying Predictive Biomarkers Irene Ng(The Univ. of Hong Kong, Hong Kong)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 10:00~10:20 Adaptation of Practice Guidelines: When East Meets West Li-Tzong Chen(Kaohsiung Medical Univ., Kaohsiung)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 10:20~10:35 Q&A Do Young Kim, Chih-Hung Hsu, Irene Ng, Li-Tzong Chen(Yonsei Univ., National Taiwan Univ., Taipei, The Univ. of Hong Kong, Hong Kong, Kaohsiung Medical Univ., Kaohsiung)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 10:50~11:10 Biomarker-Based New Drug Development in HCC Takahiro Kodama(Osaka Univ., Osaka)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 11:10~11:30 Translational Research: The Impact from Research in Epigenomics Jeon Ah Jung(Mirxes, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 11:30~11:50 Translational Research: The Impact from Research in Spatial Transcriptomics Amkur Sharma(Harry Perkins Institute of Medical Research, Perth)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 11:50~12:10 The Promise of Immuno-Neoadjuvant Therapy in HCC Toh Han Chong(National Cancer Centre Singapore, Singapore)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 12:10~12:25 Q&A Takahiro Kodama, Jeon Ah Jung, Amkur Sharma, Toh Han Chong(Osaka Univ., Osaka, Mirxes, Singapore, Harry Perkins Institute of Medical Research, Perth, National Cancer Centre Singapore, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 13:30~13:50 Early HCC and Treatment with Curative Intent - Has Adjuvant Therapy Opened a New Paradigm? Linda Wong(Univ. of Hawaii, Honululu)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 13:50~14:10 Intermediate-Stage HCC: Re-Defining the Role of Liver-Directed Therapy Hyo-Cheol Kim(Seoul National Univ.)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 14:10~14:30 Intermediate-Stage HCC: Expanding the Role of Systemic Therapy Masafumi Ikeda(National Cancer Center Hospital East, Kashiwa)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 14:30~14:50 Advanced HCC: Novel Approaches beyond Imbrave150 and Himalaya Chih-Hung Hsu(National Taiwan Univ., Taipei)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 14:50~15:05 Q&A Linda Wong, Hyo-Cheol Kim, Masafumi Ikeda, Chih-Hung Hsu(Univ. of Hawaii, Honululu, Seoul National Univ., National Cancer Center Hospital East, Kashiwa, National Taiwan Univ., Taipei)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 15:20~15:45 Investigator-Initiated Trials for HCC in the Asia-Pacific Region Pierce Chow(National Cancer Centre Singapore, Singapore)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 15:45~16:05 Apple Association as a Platform for Future International Research Collaboration Jinsil Seong(Yonsei Univ.)

±³À°½Ã°£ 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 16:05~16:25 Promoting the Next-Generation Liver Cancer Experts to the Global Arena Ann-Lii Cheng (National Taiwan Univ. Cancer Center,Taipei)

Åä·Ð 07¿ù 06ÀÏ ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼­¿ï Æĸ£³ª½º 2F Room D 16:25~16:40 Q&A Pierce Chow, Jinsil Seong, Ann-Lii Cheng (National Cancer Centre Singapore, Singapore, Yonsei Univ., National Taiwan Univ. Cancer Center,Taipei)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑ°£¾ÏÇÐȸ APPLE 2023 (The 13th Asia-Pacific Primary Liver Cancer Expert Meeting) - Day1 : 2023-07-06""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û APCCMI 2023 & ´ëÇÑÀÓ»ó¹Ì»ý¹°ÇÐȸ Á¦26Â÷ Çмú´ëȸ (1ÀÏÂ÷) : 2023-07-06
´ÙÀ½±Û 2023 ´ëÇѽÅÀåÇÐȸ ºÎ¿ï°æÁöȸ Á¦ 108Â÷ ¿¬¼ö±³À° : 2023-07-06
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
60 ºÎ»ê 2018³â ´ëÇѼÒÈ­±â¿¬°üÇÐȸ ºÎ¿ï°æÁöȸ ¿¬¼ö°­Á : 2018-08-18 0 675 2018-07-28
59 ¼­¿ï ´ëÇÑ»êºÎÀΰúÀÇ»çȸ&Çѱ¹¹ß»ý»ý¹°ÇÐȸ Joint Symposium : 2018-08-18 0 1,080 2018-07-28
58 ¼­¿ï ´ëÇѺ´¸®ÇÐȸ 8th Ç÷¾×º´¸® ¿¬¼ö±³À° : 2018-08-18 0 706 2018-07-28
57 ¼­¿ï ´ëÇѴٹ߼º°æÈ­ÁõÇÐȸ 2018³â ¿¬·ÊÇмú´ëȸ : 2018-08-18 0 835 2018-07-28
56 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ 2018³âµµ Á¦2Â÷ ÁöµµÀü¹®ÀÇ ±³À° : 2018-08-17 0 857 2018-07-28
55 °­¿ø ´ëÇѽÉÀåÇÐȸ Ç÷°ü¿¬±¸È¸ ÇÏ°è½ÉÆ÷Áö¾ö : 2018-08-17 0 1,286 2018-07-28
54 ¼­¿ï Á߾Ӵ뺴¿ø »êºÎÀΰú žÆÃÊÀ½ÆÄ ¿¬¼Ó°­Á : 2018-08-16 0 659 2018-07-28
53 ¼­¿ï °Ç±¹´ëÇб³º´¿ø À̺ñÀÎÈÄ°ú °³¿øÀÇ ¿¬¼ö±³À°(ÈĵÎÁúȯ) : 2018-08-16 0 728 2018-07-28
52 ¼­¿ï ´ëÇÑÀÇ»çÇùȸ [Á¦27±â ÀÇ·áÁ¤Ã¥ÃÖ°íÀ§°úÁ¤] °Ç°­º¸Çè ¼ö°¡°áÁ¤ : 2018-08-16 0 865 2018-07-28
51 ¼­¿ï Çѱ¹¿ªÇÐȸ Biomarker ¸¦ ÀÌ¿ëÇÑ ¿¬±¸ ¼³°è¿Í ºÐ¼® : 2018-08-14 0 1,277 2018-07-28
50 ¼­¿ï Á¦240ȸ ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ ¿ù·Ê ÇмúÁý´ãȸ : 2018-08-14 0 423 2018-07-28
49 ¼­¿ï Çѱ¹¿ªÇÐȸ MR ±â¹Ý À¯Àüü ¿ªÇבּ¸¿Í °ø°ø°Ç°­ÀÚ·á ±â¹Ý Outcome research : 2018-08-13 0 646 2018-07-28
48 ¼­¿ï °¡Å縯´ëÇб³¼­¿ï¼º¸ðº´¿ø 2018 Catholic Orthopedic Symposium II - Foot & Ankle, Hip, Knee - : 2018-08-12 0 1,100 2018-07-28
47 ¼­¿ï 2018 ´ëÇÑÈäºÎ¿µ»óÀÇÇÐȸ ¿¬¼ö°­Á : 2018-08-12 0 539 2018-07-28
46 ¼­¿ï 2018 Á¦ 2ȸ ´ëÇѺ¹¸·¾ÏÇÐȸ ±¹Á¦½ÉÆ÷Áö¾ö : 2018-08-11 0 1,421 2018-07-28
1401 | 1402 | 1403 | 1404 | 1405 | 1406 | 1407 | 1408 | 1409
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷